Siegfried Holding AG : CMD indicated the continuation of Siegfried’s successful corporate strategy
>Marcel Imwinkelried to continue the successful Evolve approach - Siegfried's first CMD took place on 24 October in Barberà del Vallès (Spain), where the company took over production facilities for its Drug Products Division from Novartis in September 2020. The CMD was also a good opportunity to introduce Siegfried's new CEO, Marcel Imwinkelried, who took over his new role on 1 September, to analysts and investors. During the CMD the company did not provide any news s...Siegfried Holding is a worldwide pharmaceutical supplier with production sites in Switzerland, Malta, and in the United States. Co. develops manufacturing processes for active pharmaceutical ingredients and their intermediates and manufactures these (Drug Substances). Co. also produces finished pharmaceutical products (Drug Products).
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.